Bristol Rethinking Sales Model, May Try New Approach To Sampling
Executive Summary
Bristol-Myers Squibb is reexamining the role of sales forces to find new ideas for reaching physicians
You may also be interested in...
Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005
Bristol-Myers Squibb will continue to promote Pravachol over the near term despite declining sales for the statin as wholesalers prepare for generic competition in 2006
Bristol Prepares For Life After Pravachol: Support Will Continue Into 2005
Bristol-Myers Squibb will continue to promote Pravachol over the near term despite declining sales for the statin as wholesalers prepare for generic competition in 2006
Primary Care Rx Market Offers Second-Rate Return On Investment – Bristol
Pharmaceutical companies marketing primary care products are unlikely to see a significant return on their investment, Bristol-Myers Squibb CFO Andrew Bonfield declared June 10